Drug
Budigalimab
Budigalimab: highest development phase Phase 2, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| Budigalimab NCT06032546 | Phase 2 | Human Immuno-deficiency Virus (HIV) Disease |
Latest
No recent events.
Follow Budigalimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.